Literature DB >> 14531389

Contrast media in magnetic resonance angiography.

Georg M Bongartz.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14531389     DOI： 10.1007/s00330-003-1906-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  10 in total

1.  Optimizing of gadolinium-enhanced MR angiography by manipulation of acquisition and scan delay times.

Authors:  J J Lee; Y Chang; P J Tirman; H K Ryum; S K Lee; Y S Kim; D S Kang
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 2.  Contrast-enhanced magnetic resonance angiography of peripheral vessels. Different contrast agent applications and sequence strategies: a review.

Authors:  M Boos; M Lentschig; K Scheffler; G M Bongartz; W Steinbrich
Journal:  Invest Radiol       Date:  1998-09       Impact factor: 6.016

3.  Clinical utility of contrast-enhanced MR angiography.

Authors:  G M Bongartz; M Boos; K Winter; H Ott; K Scheffler; W Steinbrich
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

4.  Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study.

Authors:  B Tombach; C Bremer; P Reimer; K Kisters; R M Schaefer; V Geens; W Heindel
Journal:  Radiology       Date:  2001-03       Impact factor: 11.105

5.  0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography.

Authors:  M Goyen; T C Lauenstein; C U Herborn; J F Debatin; S Bosk; S G Ruehm
Journal:  J Magn Reson Imaging       Date:  2001-11       Impact factor: 4.813

6.  The effect of injection rate on time-resolved contrast-enhanced peripheral MRA.

Authors:  T J Carroll; F R Korosec; J S Swan; T F Hany; T M Grist; C A Mistretta
Journal:  J Magn Reson Imaging       Date:  2001-10       Impact factor: 4.813

7.  Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.

Authors:  G Adam; J Neuerburg; E Spüntrup; A Mühler; K Scherer; R W Günther
Journal:  Magn Reson Med       Date:  1994-11       Impact factor: 4.668

Review 8.  Tolerance data of Gd-DTPA: a review.

Authors:  H P Niendorf; J C Dinger; J Haustein; I Cornelius; A Alhassan; W Clauss
Journal:  Eur J Radiol       Date:  1991 Jul-Aug       Impact factor: 3.528

9.  Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography.

Authors:  Annette Hentsch; Manuela A Aschauer; Jörn O Balzer; Joachim Brossmann; Hans P Busch; Kirsten Davis; Philippe Douek; Franz Ebner; Jos M A van Engelshoven; Michaela Gregor; Christian Kersting; Patrick R Knüsel; Edward Leen; Tim Leiner; Christian Loewe; Simon McPherson; Peter Reimer; Fritz K W Schäfer; Matthias Taupitz; Siegfried A Thurnher; Bernd Tombach; Robin Wegener; Dominik Weishaupt; James F M Meaney
Journal:  Eur Radiol       Date:  2003-03-25       Impact factor: 5.315

10.  Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material.

Authors:  Jörn O Balzer; Christian Loewe; Kirsten Davis; Mathias Goyen; Tim Leiner; James F M Meaney; Christiane Pöckler-Schöniger; Gernot Schulte-Altedorneburg; Bernd Tombach; Rolf Vosshenrich; Robin Wegener
Journal:  Eur Radiol       Date:  2002-12-03       Impact factor: 5.315
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.